Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
May 14, 2018
Cost-effectiveness of sensor-augmented pump therapy in two different patient populations with type 1 diabetes in Italy
A Nicolucci, M C Rossi, D D'Ostilio, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia
|
July 31, 2004
[Cost-efectiveness of Ibersartan in type II diabetic nephropathy with hypertension. A Spanish perspective]
A J Palmer, L Annemans, S Roze, et al.
Journal of Human Hypertension
|
April 30, 2004
An economic evaluation of the Irbesartan in Diabetic Nephropathy Trial (IDNT) in a UK setting
A J Palmer, L Annemans, S Roze, et al.
Deutsche Medizinische Wochenschrift (1946)
|
July 27, 2006
[Clinical and health economic implications of early treatment with irbesartan of patients with type 2 diabetes mellitus, hypertension and nephropathy]
A J Palmer, S Roze, R A Rodby, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
May 13, 2015
Cost-effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in Type 1 diabetes: a systematic review
S Roze, J Smith-Palmer, W Valentine, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
December 9, 2014
Health-economic analysis of real-time continuous glucose monitoring in people with Type 1 diabetes
S Roze, R Saunders, A-S Brandt, et al.
International Journal of Clinical Practice
|
September 14, 2007
Cost-effectiveness of raising HDL cholesterol by adding prolonged-release nicotinic acid to statin therapy in the secondary prevention setting: a French perspective
S Roze, J Ferrières, E Bruckert, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Health-Economic Comparison of Sensor-Augmented Pump With Low Glucose Suspend Versus Insulin Pump Alone For The Treatment of Hypo-Prone Type 1 Diabetes In Hungary
S Roze, P Lynch, I Boncz, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Health-Economic Comparison of Sensor-Augmented Pump With Low Glucose Suspend Versus Insulin Pump Alone For The Treatment Of Hypo-Prone Type 1 Diabetes In Slovakia
S Roze, P Lynch, R Machova, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Cost-Effectiveness Comparison Of Botulinum Toxin Type A Plus Best Supportive Care Versus Best Supportive Care Alone In The Treatment Of Idiopathic Overactive Bladder With Urinary Incontinence Among Patients Not Adequately Managed By Anticholinergic Therapy In France
A Ruffion, M Velard, C Loveman, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
May 14, 2018
Cost-effectiveness of sensor-augmented pump therapy in two different patient populations with type 1 diabetes in Italy
A Nicolucci, M C Rossi, D D'Ostilio, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia
|
July 31, 2004
[Cost-efectiveness of Ibersartan in type II diabetic nephropathy with hypertension. A Spanish perspective]
A J Palmer, L Annemans, S Roze, et al.
Journal of Human Hypertension
|
April 30, 2004
An economic evaluation of the Irbesartan in Diabetic Nephropathy Trial (IDNT) in a UK setting
A J Palmer, L Annemans, S Roze, et al.
Deutsche Medizinische Wochenschrift (1946)
|
July 27, 2006
[Clinical and health economic implications of early treatment with irbesartan of patients with type 2 diabetes mellitus, hypertension and nephropathy]
A J Palmer, S Roze, R A Rodby, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
May 13, 2015
Cost-effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in Type 1 diabetes: a systematic review
S Roze, J Smith-Palmer, W Valentine, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
December 9, 2014
Health-economic analysis of real-time continuous glucose monitoring in people with Type 1 diabetes
S Roze, R Saunders, A-S Brandt, et al.
International Journal of Clinical Practice
|
September 14, 2007
Cost-effectiveness of raising HDL cholesterol by adding prolonged-release nicotinic acid to statin therapy in the secondary prevention setting: a French perspective
S Roze, J Ferrières, E Bruckert, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Health-Economic Comparison of Sensor-Augmented Pump With Low Glucose Suspend Versus Insulin Pump Alone For The Treatment of Hypo-Prone Type 1 Diabetes In Hungary
S Roze, P Lynch, I Boncz, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Health-Economic Comparison of Sensor-Augmented Pump With Low Glucose Suspend Versus Insulin Pump Alone For The Treatment Of Hypo-Prone Type 1 Diabetes In Slovakia
S Roze, P Lynch, R Machova, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Cost-Effectiveness Comparison Of Botulinum Toxin Type A Plus Best Supportive Care Versus Best Supportive Care Alone In The Treatment Of Idiopathic Overactive Bladder With Urinary Incontinence Among Patients Not Adequately Managed By Anticholinergic Therapy In France
A Ruffion, M Velard, C Loveman, et al.
Page
of 3